| Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline SS Chang, BH Bochner, R Chou, R Dreicer, AM Kamat, SP Lerner, ... The Journal of urology 198 (3), 552-559, 2017 | 850 | 2017 |
| Prostate cancer, version 1.2016 JL Mohler, AJ Armstrong, RR Bahnson, AV D'Amico, BJ Davis, ... Journal of the National Comprehensive Cancer Network 14 (1), 19-30, 2016 | 739 | 2016 |
| Pediatric testicular torsion epidemiology using a national database: incidence, risk of orchiectomy and possible measures toward improving the quality of care LC Zhao, TB Lautz, JJ Meeks, M Maizels The Journal of urology 186 (5), 2009-2013, 2011 | 299 | 2011 |
| A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer JJ Meeks, J Bellmunt, BH Bochner, NW Clarke, S Daneshmand, ... European urology 62 (3), 523-533, 2012 | 284 | 2012 |
| Stricture recurrence after urethroplasty: a systematic review JJ Meeks, BA Erickson, MA Granieri, CM Gonzalez The Journal of urology 182 (4), 1266-1270, 2009 | 282 | 2009 |
| Bladder cancer, version 5.2017, NCCN clinical practice guidelines in oncology PE Spiess, N Agarwal, R Bangs, SA Boorjian, MK Buyyounouski, ... Journal of the National Comprehensive Cancer Network 15 (10), 1240-1267, 2017 | 247 | 2017 |
| NCCN guidelines insights: bladder cancer, version 5.2018 TW Flaig, PE Spiess, N Agarwal, R Bangs, SA Boorjian, ... Journal of the national comprehensive cancer network 16 (9), 1041-1053, 2018 | 237 | 2018 |
| Dax1 is required for testis determination JJ Meeks, J Weiss, JL Jameson Nature genetics 34 (1), 32-33, 2003 | 235 | 2003 |
| Diagnosis and treatment of early stage testicular cancer: AUA guideline A Stephenson, SE Eggener, EB Bass, DM Chelnick, S Daneshmand, ... The Journal of urology 202 (2), 272-281, 2019 | 214 | 2019 |
| Sox3 Is Required for Gonadal Function, but Not Sex Determination, in Males and Females J Weiss, JJ Meeks, L Hurley, G Raverot, A Frassetto, JL Jameson Molecular and cellular biology 23 (22), 8084-8091, 2003 | 213 | 2003 |
| Phenotypic spectrum of mutations in DAX-1 and SF-1 JC Achermann, JJ Meeks, JL Jameson Molecular and cellular endocrinology 185 (1-2), 17-25, 2001 | 196 | 2001 |
| Scanometric microRNA array profiling of prostate cancer markers using spherical nucleic acid–gold nanoparticle conjugates AH Alhasan, DY Kim, WL Daniel, E Watson, JJ Meeks, CS Thaxton, ... Analytical chemistry 84 (9), 4153-4160, 2012 | 184 | 2012 |
| An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer SV Lindskrog, F Prip, P Lamy, A Taber, CS Groeneveld, ... Nature communications 12 (1), 2301, 2021 | 175 | 2021 |
| Emerging therapeutic targets in bladder cancer BA Carneiro, JJ Meeks, TM Kuzel, M Scaranti, SA Abdulkadir, FJ Giles Cancer Treatment Reviews 41 (2), 170-178, 2015 | 175 | 2015 |
| Dax1 regulates testis cord organization during gonadal differentiation JJ Meeks, SE Crawford, TA Russell, K Morohashi, J Weiss, JL Jameson Oxford University Press for The Company of Biologists Limited 130 (5), 1029-1036, 2003 | 159 | 2003 |
| The cancer genome atlas expression subtypes stratify response to checkpoint inhibition in advanced urothelial cancer and identify a subset of patients with high survival … J Kim, D Kwiatkowski, DJ McConkey, JJ Meeks, SS Freeman, J Bellmunt, ... European urology 75 (6), 961-964, 2019 | 152 | 2019 |
| Prospective analysis of erectile dysfunction after anterior urethroplasty: incidence and recovery of function BA Erickson, MA Granieri, JJ Meeks, JP Cashy, CM Gonzalez The Journal of urology 183 (2), 657-661, 2010 | 149 | 2010 |
| Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy L Wang, Z Zhao, PA Ozark, D Fantini, SA Marshall, EJ Rendleman, ... Nature medicine 24 (6), 758-769, 2018 | 148 | 2018 |
| Immunosuppressive IDO in cancer: mechanisms of action, animal models, and targeting strategies L Zhai, A Bell, E Ladomersky, KL Lauing, L Bollu, JA Sosman, B Zhang, ... Frontiers in immunology 11, 1185, 2020 | 143 | 2020 |
| Circulating microRNA signature for the diagnosis of very high-risk prostate cancer AH Alhasan, AW Scott, JJ Wu, G Feng, JJ Meeks, CS Thaxton, CA Mirkin Proceedings of the National Academy of Sciences 113 (38), 10655-10660, 2016 | 138 | 2016 |
